These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 24752957
1. Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial. Kalita J, Misra UK, Prasad S, Bhoi SK. J Antimicrob Chemother; 2014 Aug; 69(8):2246-51. PubMed ID: 24752957 [Abstract] [Full Text] [Related]
6. Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen. Heemskerk AD, Nguyen MTH, Dang HTM, Vinh Nguyen CV, Nguyen LH, Do TDA, Nguyen TTT, Wolbers M, Day J, Le TTP, Nguyen BD, Caws M, Thwaites GE. Clin Infect Dis; 2017 Jul 01; 65(1):20-28. PubMed ID: 28472255 [Abstract] [Full Text] [Related]
7. Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis. Pouplin T, Bang ND, Toi PV, Phuong PN, Dung NH, Duong TN, Caws M, Thwaites GE, Tarning J, Day JN. BMC Infect Dis; 2016 Apr 02; 16():144. PubMed ID: 27039088 [Abstract] [Full Text] [Related]
10. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. Misra UK, Kalita J, Nair PP. J Neurol Sci; 2010 Jun 15; 293(1-2):12-7. PubMed ID: 20421121 [Abstract] [Full Text] [Related]
11. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. Boeree MJ, Heinrich N, Aarnoutse R, Diacon AH, Dawson R, Rehal S, Kibiki GS, Churchyard G, Sanne I, Ntinginya NE, Minja LT, Hunt RD, Charalambous S, Hanekom M, Semvua HH, Mpagama SG, Manyama C, Mtafya B, Reither K, Wallis RS, Venter A, Narunsky K, Mekota A, Henne S, Colbers A, van Balen GP, Gillespie SH, Phillips PPJ, Hoelscher M, PanACEA consortium. Lancet Infect Dis; 2017 Jan 15; 17(1):39-49. PubMed ID: 28100438 [Abstract] [Full Text] [Related]
12. Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru. Morales S, Ramos W, Vílchez R, Pérez J, Alvarado M. Neurologia; 2011 May 15; 26(4):220-6. PubMed ID: 21163196 [Abstract] [Full Text] [Related]
14. [A case of tuberculous meningitis complicated with multiple drug hypersensitivity to antituberculosis agents]. Arai M. Rinsho Shinkeigaku; 2015 May 15; 55(2):123-5. PubMed ID: 25746078 [Abstract] [Full Text] [Related]
15. The chemotherapy of tuberculous meningitis in children and adults. Donald PR. Tuberculosis (Edinb); 2010 Nov 15; 90(6):375-92. PubMed ID: 20810322 [Abstract] [Full Text] [Related]
16. [Efficacy and safety of first-line anti-tuberculosis drugs combined with Linezolid for the treatment of pediatric tuberculous meningitis in real-word practice]. Ai T, Jiang L, Liu QB, Bai Y, Yang Y, Sun FJ, Jia YT, Zhou YJ, Zhang ZZ. Zhonghua Er Ke Za Zhi; 2024 Aug 02; 62(8):715-720. PubMed ID: 39039872 [Abstract] [Full Text] [Related]
17. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J, British Infection Society. J Infect; 2009 Sep 02; 59(3):167-87. PubMed ID: 19643501 [Abstract] [Full Text] [Related]
18. Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China. Song Y, Shu W, Pei Y, Du J, Wu G, Wang H, Mi F, Liu F, Ma L, Xie L, Kong Z, Wu X, Liu R, Chen H, Li H, Ge Q, Nie L, Lv Z, Huang X, Li M, Jiang M, Chen X, Cai Q, Chen W, Liu Y, Miao Y, Tang Y, Chen Y, Geng S, Zhou Q, Liu Y, Pang Y, Gao M. BMC Med; 2024 Sep 19; 22(1):401. PubMed ID: 39300460 [Abstract] [Full Text] [Related]